2-氨基-4-(3,4-二氯苯基)噻唑 | 39893-80-6

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-4-(3,4-二氯苯基)噻唑
• 中文别名: 噻唑-2-胺,4-(3,4-二氯苯基)-；4-(3,4-二氯苯基)-1,3-噻唑-2-胺；4-(3,4-二氯苯基)噻唑-2-胺；4-(3,4-二氯苯基)-2-硫佐拉敏；[4-(3,4-二氯苯基)噻唑-2-基]胺
• 英文名称: 4-(3,4-dichloro-phenyl)-thiazol-2-ylamine
• 英文别名: 4-(3,4-dichlorophenyl)thiazol-2-amine；2-amino-4-(3,4-dichlorophenyl)thiazole；4-(3,4-Dichlorophenyl)-1,3-thiazol-2-amine
• CAS: 39893-80-6
• 化学式: C₉H₆Cl₂N₂S
• mdl: MFCD00466323
• 分子量: 245.132
• InChiKey: UWAXMUSNRIUHRQ-UHFFFAOYSA-N

物化性质

• 熔点：
  161.0 to 165.0 °C

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2934100090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(3,4-Dichloro-phenyl)-thiazol-2-ylamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(3,4-Dichloro-phenyl)-thiazol-2-ylamine
CAS number: 39893-80-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H6Cl2N2S
Molecular weight: 245.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-4-(3,4-二氯苯基)噻唑 在 碘 、 碘酸 作用下， 以 水 为溶剂， 反应 0.18h， 生成 4-(3,4-dichloro-phenyl)-5-iodo-thiazol-2-ylamine
  参考文献：
  名称：

  一种快速、温和、高效的 2-氨基噻唑 C-5 碘化/硫氰化方法

  摘要：

  图形摘要 摘要 开发了一种高效、绿色、快速的多任务协议，用于使用碘酸和 PEG-400 水溶液选择性地 C-5 取代 2-氨基噻唑。该方法发现适用于 C-5 取代，即分别使用碘和硫氰酸铵对 2-氨基噻唑进行碘化和硫氰化。碘酸被发现是一种良好的氧化剂，PEG-400 水溶液作为绿色反应溶剂。

  DOI：

  10.1080/10426507.2016.1149851
• 作为产物：
  描述：

  3,4-二氯苯乙酮 在 N-溴代丁二酰亚胺(NBS) 、 柠檬酸 作用下， 以 乙醇 、 水 为溶剂， 反应 0.32h， 生成 2-氨基-4-(3,4-二氯苯基)噻唑
  参考文献：
  名称：

  柠檬酸一锅中通过C–B​​r，C–S和C–N键的形成从酮中合成2,4-二取代的噻唑：一种绿色方法

  摘要：

  已开发出一种改进的，更环保的方案，可通过一步一步从现成的酮类N-溴代琥珀酰亚胺（NBS），C-Br，C-S和C-N键的形成中合成2,4-二取代的噻唑，在回流条件下，柠檬酸在乙醇和水（3：1）的混合物中由柠檬酸催化硫脲。该方法的优点是无需分离催泪性α-溴代酮，易于操作，反应曲线更干净，底物范围宽，无需色谱纯化和适合大规模合成。

  DOI：

  10.1002/jccs.201700200

文献信息

• [EN] GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE GLYCOLATE OXYDASE POUR LE TRAITEMENT D'UNE MALADIE
  申请人：BIOMARIN PHARM INC

  公开号：WO2020257487A1

  公开（公告）日：2020-12-24

  Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

  本文描述了化合物、制备这种化合物的方法、含有这种化合物的药物组合物和药物，以及使用这种化合物治疗或预防与甘氧酸代谢缺陷相关的疾病或紊乱的方法，例如与甘氧酸氧化酶（GO）或草酸代谢变化相关的疾病或紊乱。这些疾病或紊乱包括与产生过多草酸相关的甘氧酸代谢紊乱，例如原发性高草酸尿症。
• N-(5-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS
  申请人：Schmitz Ulrich Franz

  公开号：US20070265265A1

  公开（公告）日：2007-11-15

  Disclosed are compounds having Formula (I) and the compositions and methods thereof for treating or preventing a viral infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, R 2 , m, R, V, W, T, Z, R 1 , Y, and p are disclosed herein.

  揭示了具有Formula (I)的化合物，以及用于治疗或预防由Flaviviridae病毒家族中的病毒至少部分介导的病毒感染的组合物和方法，其中A、R2、m、R、V、W、T、Z、R1、Y和p在此处被揭示。
• Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPAR&amp;gamma;
  作者：Liang Ma、Taijin Wang、Min Shi、Haoyu Ye

  DOI：10.2147/dddt.s106406

  日期：——

  glucose and lipid homeostasis, and PPARγ ligands possess therapeutic potential in these as well as other areas. In this study, a series of phenylthiazole acids have been synthesized and evaluated for agonistic activity by a convenient fluorescence polarization-based PPARγ ligand screening assay. Compound 4t, as a potential PPARγ agonist with half maximal effective concentration (EC50) 0.75±0.20 μM, exhibited

  过氧化物酶体增殖物激活受体γ（PPARγ）是配体介导的转录因子，在葡萄糖和脂质体内平衡中起关键作用，PPARγ配体在这些以及其他领域具有治疗潜力。在这项研究中，已经合成了一系列苯基噻唑酸，并通过方便的基于荧光偏振的PPARγ配体筛选测定法评估了其激动活性。化合物4t作为潜在的PPARγ激动剂，最大有效浓度（EC50）为一半，为0.75±0.20μM，其体外效力可与0.83±0.14μM的阳性对照罗格列酮媲美。分子对接和分子动力学模拟表明，苯基噻唑酸4t与PPARγ复合物活性位点的氨基酸残基稳定地相互作用，
• Synthesis, characterization, biological activity, and 3D-QSAR studies on some novel class of pyrrole derivatives as antitubercular agents
  作者：Shrinivas D. Joshi、Uttam A. More、Sheshagiri R. Dixit、Haresh H. Korat、Tejraj M. Aminabhavi、Aravind M. Badiger

  DOI：10.1007/s00044-013-0709-y

  日期：2014.3

  designed, synthesized, and their structures have been elucidated along with the evaluation of antitubercular activity against Mycobacterium tuberculosis H37Rv using the microplate alamar blue assay method and antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, and Escherichia coli by broth micro-dilution assay method. Structural activity relationships and 3D-QSAR

  摘要设计，合成了一系列新的吡咯衍生物，并阐明了它们的结构，并使用微孔板阿拉玛蓝法评估了其对结核分枝杆菌H 37 Rv的抗结核活性以及对金黄色葡萄球菌，枯草芽孢杆菌，肺炎克雷伯菌的抗菌活性，以及通过肉汤微稀释法测定的大肠杆菌。结构活性关系和3D-QSAR分析已通过拓扑异构体比较分子场分析（CoMFA）进行。使用42个训练集和8个活性化合物的测试集来开发显示交叉验证相关系数（q 2）为0.815，预测标准误差为0.36，非交叉验证相关系数（r 2）为0.973，六项估计的标准误差为0.14。 图形概要合成; 频谱和3D-QSAR研究；描述了一系列新颖的吡咯衍生物的抗细菌，抗结核和细胞毒性活性。
• Solid state thiazole-based fluorophores: Promising materials for white organic light emitting devices
  作者：Kumar Godugu、Sultana Shaik、Mohammad Khaja Mohinuddin Pinjari、Trivikram Reddy Gundala、Dwaraka Viswanath Chellappa Subramanyam、Subramanyam Sarma Loka、Haranath Divi、Vemula Venkatramu、Chinna Gangi Reddy Nallagondu

  DOI：10.1016/j.dyepig.2020.109077

  日期：2021.3

  solid state white light emissive thiazole-based donor-acceptor (D-A) type fluorophores, 2-(3-pyridyl)/2-aminothiazoles from ω-bromomethylketones and pyridine-3-carbothioamide/thiourea in the presence of silica-supported HClO4 as a reusable solid Brønsted acid catalyst at RT. The photophysical and electrochemical properties of these compounds have been derived. Most of the studied D-A type solid thiazole-based

  已开发出一种简便且更有效的无溶剂机械化学合成路线，用于合成一系列固态白光发射的噻唑基供体-受体（DA）型荧光团，2-（3-吡啶基）/ 2-氨基噻唑在室温下，作为可重复使用的固体布朗斯台德酸催化剂，在二氧化硅负载的HClO 4存在下，ω-溴甲基酮和吡啶-3-碳硫酰胺/硫脲。已经推导了这些化合物的光物理和电化学性质。大多数研究过的DA型基于噻唑的固体荧光团都发出白光，并且可以通过在第4个引入各种取代基从温暖的（理想的）冷的白光进行调谐。2-（3-吡啶基）/ 2-氨基噻唑的位置。此外，发现标题化合物的HOMO和LUMO能级分别在-5.52eV至-5.72eV和-1.84eV至-2.45eV的范围内。这些水平的噻唑基荧光团的寿命已通过发光衰减曲线确定，发现范围为7.7–11μs。合成的噻唑基荧光团的光物理和电化学性质表明，该化合物可能是用于白色有机发光器件的有前途的材料。

表征谱图